PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2.72%
Negative net income growth while Medical - Pharmaceuticals median is 0.00%. Seth Klarman would suspect a firm-specific problem if peers maintain profit growth.
14.36%
D&A growth under 50% of Medical - Pharmaceuticals median of 2.12%, or significantly exceeding it. Jim Chanos would suspect overcapacity or misallocated capex if new assets do not pay off quickly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-320.18%
Working capital is shrinking yoy while Medical - Pharmaceuticals median is 0.00%. Seth Klarman would see an advantage if sales remain robust.
No Data
No Data available this quarter, please select a different quarter.
-120.77%
Inventory shrinks yoy while Medical - Pharmaceuticals median is 0.00%. Seth Klarman would see a working capital edge if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-76.23%
Other WC usage shrinks yoy while Medical - Pharmaceuticals median is 0.00%. Seth Klarman would see an advantage if top-line is stable or growing.
103.27%
Growth of 103.27% while Medical - Pharmaceuticals median is zero at 0.00%. Walter Schloss would question expansions or one-off revaluations explaining the difference.
-42.18%
Negative CFO growth while Medical - Pharmaceuticals median is 9.09%. Seth Klarman would suspect a firm-specific operational weakness if peers maintain growth.
27.72%
CapEx growth of 27.72% while Medical - Pharmaceuticals median is zero at 0.00%. Walter Schloss would question expansions or upgrades behind the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.82%
Growth of 57.82% while Medical - Pharmaceuticals median is zero at 0.00%. Walter Schloss questions intangible or special projects explaining that difference.
34.05%
Investing flow of 34.05% while Medical - Pharmaceuticals median is zero at 0.00%. Walter Schloss would question expansions or deals prompting that difference.
10.38%
Debt repayment growth of 10.38% while Medical - Pharmaceuticals median is zero at 0.00%. Walter Schloss wonders if expansions or a shift in capital structure drive that difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.